Recap: NovoCure Q3 Earnings

NovoCure (NASDAQ:NVCR) reported its Q3 earnings results on Thursday, October 28, 2021 at 06:00 AM.

Here's what investors need to know about the announcement.

NovoCure missed their estimated earnings by 85.71%, reporting an EPS of $-0.13 versus an estimate of $-0.07, which surprised analysts.

Revenue was up $946,000 from the same period last year.

Last quarter the company missed on EPS by $0.15, which was followed by a 6.09% drop in the share price the next day.

Here's a look at NovoCure's past performance:

Quarter	Q2 2021	Q1 2021	Q4 2020	Q3 2020
EPS Estimate	0.01	0.02	0.12	0.03
EPS Actual	-0.14	-0.04	0.04	0.09
Revenue Estimate	141.89M	139.36M	141.29M	120.24M
Revenue Actual	133.52M	134.69M	143.95M	132.66M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

To add Benzinga News as your preferred source on Google, click here.